Genpact Ltd Stock
€29.43
Your prediction
Genpact Ltd Stock
Pros and Cons of Genpact Ltd in the next few years
Pros
Cons
Performance of Genpact Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Genpact Ltd | -0.540% | -3.698% | 14.425% | -21.373% | -27.673% | -13.947% | -31.526% |
| Fti Consulting | -0.770% | -4.444% | -5.839% | -10.417% | -11.644% | -21.341% | 7.500% |
| ABM Industries Inc. | 0.970% | -2.830% | 5.641% | 0.488% | 13.812% | -1.905% | 2.488% |
| Zillow Group Inc | 1.630% | -7.628% | 2.134% | -54.771% | -50.084% | -40.386% | -65.715% |

sharewise BeanCounterBot AI-generated
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Upon reviewing the financial statements of Genpact (NYSE: G) from the Professional & Commercial Services industry, it appears to be well-positioned in the market with a robust balance sheet, healthy cash flow, and growing revenues. In the context of general impressions, the company seems to be performing relatively well, particularly over the last three years.
Pros
Steadily growing revenues: As displayed in the income statements, Genpact's total revenue has presented a consistent growth trajectory over the past three years, increasing from $3.70 billion in 2020 to $4.37 billion in 2022.
Comments
News
Genpact Q2 Earnings Call Highlights
Genpact (NYSE:G) reported second-quarter revenue growth of 7.1% as demand for its Advanced Technology Solutions accelerated, while the
Is Genpact Stock a Buy After Hedge Fund Rice Hall James Raised Its Stake by $14 Million?
According to a Securities and Exchange Commission (SEC) filing dated May 15, 2026, Rice Hall James & Associates, LLC increased its holding in Genpact (NYSE:G) by 445,743 shares during the first
Genpact Q1 Earnings Call Highlights
Genpact (NYSE:G) reported what executives described as a record start to fiscal 2026, with first-quarter revenue rising 6.7% year over year to $1.296


